Already on semaglutide or tirzepatide with another provider? Here's how to transfer your care to 1stRX without losing progress.
Switching providers is a normal, fully supported process. If you're already on a GLP-1 medication with another provider, you can move your care to 1stRX and keep going — you don't have to start over.
The steps are the same ones every patient follows. You complete the same free online assessment, a licensed 1stRX clinician reviews your current treatment — which medication you're on, your current dose, and how long you've been taking it — and you continue your care through 1stRX going forward.
If you plan the switch around your next scheduled dose, you don't need to pause your treatment. Many patients simply time the transfer so their first 1stRX shipment arrives before their current supply runs out.
Patients switching to 1stRX keep their current dose — your 1stRX clinician will continue you on the dose you're already taking, unless they determine an adjustment is medically appropriate for you.
To make that continuation possible, it helps to have a few details ready for your intake:
Having these on hand lets your 1stRX clinician confirm and continue your care without re-starting your titration from scratch.
A few records can help speed up your switch:
This isn't a hard requirement. Your 1stRX clinician can also verify your current treatment directly with you during your consultation — but having records on hand speeds up review and confirmation of your current dose.
If there's been a break since your last injection, how you restart depends on how long that gap has been. 1stRX uses the same 45-day definition of "new to GLP-1s" that applies to starter pricing.
"New to GLP-1s" means one of two things:
This is not limited to new 1stRX patients. Existing patients who are switching back after a gap of 45 days or more also qualify for starter pricing, because they're returning at a starting dose.
You're treated as new to GLP-1 medications for pricing purposes (starter pricing applies), and your clinician will restart you at an appropriate starting dose rather than continuing your prior dose, following standard titration.
You keep your current dose, per the policy above. Because you're not "new to GLP-1s," ongoing/maintenance pricing applies.
No. Per the current-dose policy above, if you're switching without a 45+ day gap, you continue at your current dose rather than restarting titration.
Not strictly required. It helps speed up review, but your 1stRX clinician can confirm your current treatment with you directly during your consultation.
You can still complete the switch. Be ready to describe your current medication, dose, and how long you've been on it as accurately as you can during your consultation.
You can start the switch any time. Many patients plan it around their next scheduled dose to avoid any gap in treatment.
It depends on your gap. Switching patients without a 45+ day gap stay on their current dose, so ongoing/maintenance pricing applies: $149/month or $335 for a 3-month bundle for semaglutide, and $299/month or $670 for a 3-month bundle for tirzepatide. Patients with a 45+ day gap qualify for starter pricing, which is sold as a one-time, flat 3-month supply — $224 for semaglutide or $449 for tirzepatide (no monthly option). See GLP-1 Starter Pricing for the full breakdown. Compounded medications are not FDA-approved.
Take the free 5-minute assessment and find out if you're a candidate.
Start My Free Assessment →No insurance needed · Cancel anytime